Home > Insider Trading > Filing (0000899243-20-024203)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1571498	Epizyme Inc.	EPZM	Pharmaceutical Preparations (2834)	261349956

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1766032	Joseph Beaulieu	C/O Epizyme, Inc., 400 Technology Square Cambridge MA 02139	Corporate Controller	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001	Disposition	2019-09-03	971	$12.77	6,501	No	4	S	Direct
Common Stock, Par Value $0.0001	Disposition	2020-09-02	543	$12.88	5,958	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Acquisiton	2020-09-01	6,650	$0.00	6,650	$12.79

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
6,650		2030-08-31	No	4	A	Direct

Footnotes

The reporting person acquired 1,120 and 971 shares of Common Stock under the Issuer's 2013 Employee Stock Purchase Plan on February 28, 2019 and August 31, 2019, respectively, that were not previously reported on Form 4.
The reporting person acquired 543 shares of Common Stock under the Issuer's 2013 Employee Stock Purchase Plan on August 31, 2020.
Effected pursuant to a trading plan adopted on March 26, 2020 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
This option was granted on September 1, 2020 pursuant to the Company's 2013 Stock Incentive Plan with respect to 6,650 shares of Common Stock, with 25% vesting on September 1, 2021 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.